Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity

BackgroundObesity is a major public health problem of our time as a risk factor for cardiometabolic disease and the available pharmacological tools needed to tackle the obesity pandemic are insufficient. Neurotensin (NTS) is a 13 amino acid peptide, which is derived from a larger precursor hormone c...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zherui Wu, Nicolas Stadler, Amazigh Abbaci, Jin Liu, Agnès Boullier, Nicolas Marie, Olivier Biondi, Marthe Moldes, Romain Morichon, Bruno Feve, Olle Melander, Patricia Forgez
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Endocrinology
Assuntos:	LF NTS targeted therapy neurotensin obesity behavior metabolism
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fendo.2021.739287/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!